SPX -0.62% VIX 6.80%
FED'S ROSENGREN SAYS ECONOMY DOESN'T LOOK LIKE IT NEEDS INTEREST-RATE CUT 
U.S. STOCKS END LOWER AS EXPECTATIONS FOR HALF-POINT RATE CUT WANE 
STOCKS HAVE TURNED NEGATIVE IN THE FINAL HOUR OF TRADING FRIDAY 
DISNEY'S LIVE-ACTION 'LION KING' SHOULD RULE THE MOVIE WORLD ON THIS HOT WEEKEND 
YOU CAN NOW BUY TRUMP-BRANDED STRAWS TO COUNTER THE 'LIBERAL' PAPER VERSIONS 
DEEP DIVE: BIG-BANK EARNINGS POINT TO NEAR-TERM PAIN AND LONG-TERM OPPORTUNITY 
CONSUMERS REMAIN UPBEAT ABOUT U.S. ECONOMY, UNIV. OF MICH. DATA SHOW 
'RELIEF' RALLY IN BOEING A KEY FACTOR IN KEEPING DOW IN POSITIVE TERRITORY 
RED ROBIN SHARES SOAR AFTER ACTIVIST-INVESTOR OFFER 
MICROSOFT HITS ALL-TIME INTRADAY HIGH AS IT JOINS BOEING IN PACING DOW ADVANCE 
Sat, Jul 20 7:00pm


Arrowhead Pharmaceuticals Inc [ARWR]
$29.17 0.46 (1.55%)

ARWR Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 2.81 Billion
ARWR Description

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.


Visit Website

ARWR Earnings

EPS 0.25 P/E Ratio 0.00
Previous Earnings Thu, Feb 7, 2019
Latest Earnings Wed, May 8, 2019 (73 days ago) +61.97%

ARWR Dividend

Yield --
Ex-Date --
Pay Date --
History --

ARWR Charts

$10.41
52 Week Range
$30.13
Dec 24, 2018
Jul 18, 2019



Symbol Price Day % YTD %
ARWR $29.17 -1.55% 122.33%

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy